Scinovex
article Open AccessTop 1% cited

The Economic Burden of Insomnia: Direct and Indirect Costs for Individuals with Insomnia Syndrome, Insomnia Symptoms, and Good Sleepers

SLEEP · 2009 · Vol. 32(1) · pp. 55–64
Meagan DaleyCharles M. MorinMélanie LeBlancJean‐Pierre GrégoireJosée Savard

Abstract

This study suggests that the economic burden of insomnia is very high, with the largest proportion of all expenses (76%) attributable to insomnia-related work absences and reduced productivity. As the economic burden of untreated insomnia is much higher than that of treating insomnia, future clinical trials should evaluate the cost-benefits, cost-utility, and cost-effectiveness of insomnia therapies.

Sleep and related disordersYouth Substance Use and School AttendanceObesity, Physical Activity, DietInsomniaIndirect costsAbsenteeismMedicineHealth careEconomic costMedical prescriptionPsychiatryPopulationTotal cost

MeSH terms

AbsenteeismAccidentsAdolescentAdultAgedAged, 80 and overAlcoholic BeveragesCost-Benefit AnalysisEfficiencyFemaleHealth SurveysHospitalizationHumansSleep Initiation and Maintenance DisordersMale

Funding

  • Novartis
  • Sanofi
  • Merck Canada
  • Novartis Pharma
Citations
645
FWCI
26.12
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.